New Webinar Educates Physicians On Home Health Benefits And Eligibility

Amedisys, Inc. (NASDAQ: AMED) and Antidote Education Company have teamed up to present “Health Care at Home” – a webinar that will provide insights on the benefits of home health care and the eligibility requirements necessary for a patient to receive clinical services in the comfort of home.

This webinar offers continuing education credits and will educate on the benefits of home health care in preventing unnecessary re-hospitalizations, reducing health care spending and improving patient outcomes.

Amedisys Chief Medical Officer Dr. Michael Fleming and Chief Clinical Officer Kate Jones present the webinar, moderated by Chief Medical Director Kevin Henning. For more information, access the course at Antidote’s website at You can also learn more about the benefits of home health care at this blog post.

About Amedisys

Amedisys, Inc. (NASDAQ: AMED) is a leading health care at home company delivering personalized home health and hospice care to more than 360,000 patients each year. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based recovery and rehabilitation after an operation or injury, care focused on empowering them to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. The Company’s state-of-the-art advanced chronic care management programs and leading-edge technology enables it to deliver quality care based upon the latest evidence-based best practices. Amedisys is a recognized innovator, being one of the first in the industry to equip its clinicians with point-of-care laptop technology and referring physicians with an internet portal that enables real-time coordination of patient care seamlessly. Amedisys also has the industry’s first-ever nationwide Care Transitions program, designed to reduce unnecessary hospital readmissions through patient and caregiver health coaching and care coordination, which starts in the hospital and continues throughout completion of the patient’s home health plan of care. For more information about the Company, please visit:

Copyright Business Wire 2010

If you liked this article you might like

Here's What Blackstone Bought and Sold in the Fourth Quarter

Here's What Blackstone and KKR Are Buying

Republican Sweep Poised to Agitate ACA-Vulnerable Health Care Services Stocks

Blackstone, KKR Unveil Second-Quarter Stock Picks

Blackstone, KKR Stock Picks Show Distinctly Bullish Tone